Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19511078 | 0.85 | ALDH1A1 (0.35) | — | |
| SCHEMBL19511770 | 0.79 | SRC (0.46) | SRC | |
| SCHEMBL19511342 | 0.79 | SRC (0.33) | SRC | |
| SCHEMBL19511339 | 0.74 | HDAC4 (0.37) | SRC | |
| SCHEMBL19511322 | 0.74 | PARP1 (0.32) | SRC | |
| SCHEMBL10840190 | 0.71 | MEN1 (0.50) | — | |
| SCHEMBL10840724 | 0.69 | BRD4 (0.39) | — | |
| SCHEMBL10841259 | 0.69 | MEN1 (0.33) | — | |
| SCHEMBL10840679 | 0.68 | MEN1 (0.50) | ADRA2A | |
| SCHEMBL30163317 | 0.68 | MEN1 (0.50) | ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239156-B1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE OF SAME | HANWHA CHEMICAL CORP (KR) | 2023-03-01 | — | — | EP | disclosed |
| CN-107001500-B | Novel group 4 transition metal compound and use thereof | 韩华化学株式会社 | 2020-11-03 | — | — | CN | disclosed |
| US-10364302-B2 | Group 4 transition metal compound and use thereof | HANWHA CHEMICAL CORPORATION (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20180002461-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF | HANWHA CHEMICAL CORPORATION (KR) | 2018-01-04 | — | — | US | disclosed |
| EP-3239156-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE OF SAME | Hanwha Chemical Corporation (KR) | 2017-11-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002461-A1 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF | MORF4L1, TRPV4, TRPM4 | SRC 3641/4885ADRA2A 4837/4885 |
| US-10364302-B2 | Group 4 transition metal compound and use thereof | TRPM4, MORF4L1, TRPV4 | SRC 3614/4885ADRA2A 4852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.